Adenosine to Assess Complete Conduction Block During Catheter Ablation of Paroxysmal Atrial Fibrillation
A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 131 participants.
Also called NCT03032965
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 131 participants
- Sponsor
- Registry
-
NCT03032965
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States
- Registry status
- Completed
Technical summary
Registry record NCT03032965. Randomized; no masking; primary purpose treatment. Start 2011-10 (registry gives no type); primary completion 2015-07 (actual). Results posted on 2017-12-13.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Adenosine to Assess Complete Conduction Block During Catheter Ablation of Paroxysmal Atrial Fibrillation
- Condition
- Atrial Fibrillation
- Intervention (Drug)
- Adenosine
- Intervention (Drug)
- Isoproterenol
- Lead sponsor
- University of Michigan
Record details
- Record id
cardio:ct-nct03032965- Content hash
f7f4f3a60eb214a84344032984c06b0e85e3b005f7b22b8df84c62ff1d90d72d